+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

Europe Depression Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Depression Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Europe
From
Global Major Depressive Disorder Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Major Depressive Disorder Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 67 Pages
  • Global
From
Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 120 Pages
  • Global
From
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Major Depressive Disorder - Epidemiology Forecast to 2029 - Product Thumbnail Image

Major Depressive Disorder - Epidemiology Forecast to 2029

  • Report
  • March 2021
  • 30 Pages
  • Global
From
Treatment Resistant Depression Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 229 Pages
  • Global
From
Psychedelic Drugs Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026) - Product Thumbnail Image

Psychedelic Drugs Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)

  • Report
  • August 2021
  • 140 Pages
  • Global
Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 195 Pages
  • Global
From
Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 153 Pages
  • Global
From
LAMEA Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 132 Pages
From
Africa Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 80 Pages
  • Africa
From
Brazil Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Brazil Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Brazil
From
China Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

China Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • China
From
France Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

France Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • France
From
Germany Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Germany Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Germany
From
India Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • India
From
Ireland Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Ireland Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Ireland
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more